Author: Zander Fitzroy

PCOS makes weight loss hard because of insulin resistance. Learn how high insulin drives belly fat, cravings, and hormonal issues-and what to eat to break the cycle and improve your health.

Athletes on blood thinners face higher bleeding risks during sports. Learn how DOACs like apixaban, sport risk levels, and timed dosing can help you stay active safely without compromising health.

Learn which pills are safe to split and which ones can be dangerous. Save money on meds without risking your health by following expert guidelines on tablet splitting.

As of February 2025, the FDA removed the mandatory REMS program for clozapine, ending strict ANC monitoring requirements. ANC blood tests are still recommended, but no longer need to be reported to a federal system. This change improves access to the most effective treatment for treatment-resistant schizophrenia.

Learn how to report medication side effects to the FDA using MedWatch. Step-by-step guide for patients, caregivers, and healthcare providers on submitting adverse event reports to improve drug safety.

Prescribers have deep concerns about substituting generic versions of narrow therapeutic index (NTI) drugs due to small changes in blood levels that can cause serious harm. Despite FDA assurances, real-world data shows substitution risks, communication gaps, and persistent brand use among doctors.

Learn how to recognize, treat, and prevent low blood sugar (hypoglycemia) if you have diabetes. Understand symptoms, emergency treatments like glucagon, and proven prevention strategies backed by 2025 guidelines.

Therapeutic Equivalence Codes (TE Codes) tell pharmacists which generic drugs can safely replace brand-name medications. Learn how the FDA's Orange Book system saves billions while ensuring effectiveness.

Black box warnings are the FDA's strongest safety alerts for prescription drugs, signaling serious risks like death or severe injury. Learn what they mean, how they're decided, and what to do if your medication has one.

Digoxin generics can be dangerous if bioavailability varies between brands. Even FDA-approved switches may cause toxicity or treatment failure. Learn why consistent use and regular blood monitoring are critical for safety.